At about 0:00 yesterday, Beijing Healthbao launched a new version. Compared with the previous version, the query function of the new version of Beijing Healthbao nucleic acid vaccine service has changed. In the past, the vaccination status showed the vaccine type in a unified way, and then the vaccination time and vaccine manufacturer of each dose were displayed separately; now, the vaccination time, vaccine manufacturer, and vaccine type are displayed separately by dose. This also means that citizens’ sequential booster immunization with different types of new crown vaccines will be reflected in the health treasure.
Recently, with the approval of the State Council’s Joint Prevention and Control Mechanism, the National Health Commission has begun to deploy sequential booster immunizations. Previously, all target groups over the age of 18 who have been vaccinated with the inactivated vaccine of Sinopharm Zhongsheng Beijing Company, Beijing Kexing Company, Sinopharm Zhongsheng Wuhan Company or the adenovirus vector vaccine of Tianjin CanSino Company for 6 months can receive one dose. Homologous booster immunization, that is, boosting with the original vaccine.
After the implementation of the sequential booster immunization strategy, the target groups who have completed the whole process of inoculating the above three inactivated vaccines can also choose the recombinant protein vaccine of Zhifeilong Coma or the adenovirus vector vaccine of CanSino for sequential Boost immunity. For the target population, one of homologous booster immunization and sequential booster immunization can be selected.
The basic immunization program of the new coronavirus inactivated vaccine (Vero cells) is to inoculate two doses. The recommended interval between the two doses is 3 weeks or more. The booster immunization program is for people aged 18 and above who have received the second dose for 6 months. Vaccine (type 5 adenovirus vector) or one dose of recombinant SARS-CoV-2 vaccine (CHO cells).
The basic immunization program of the new coronavirus vaccine (type 5 adenovirus vector) is one dose. The booster immunization program is a booster dose of the new coronavirus vaccine (adenovirus type 5 vector) for people aged 18 and over after 6 months of basic vaccination.
The immunization schedule for recombinant novel coronavirus vaccine (CHO cells) is 3 doses, and the recommended interval between adjacent doses is 4 weeks or more. The second dose should be completed within 8 weeks after the first dose, and the third dose should be completed within 6 months after the first dose.
Text/Reporter Jiang Ruojing